Mercury Therapeutics Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Mercury Therapeutics General Information

Description

Developer of small-molecule therapeutics designed to treat metabolic, oncology, and cardiovascular diseases. The company's platform develops adenosine monophosphate-activated protein kinase activator drug candidates using proprietary discovery technology, enabling pharmaceutical researchers to advance targeted therapies for metabolic, oncology, and cardiovascular conditions.

Contact Information

Website
www.mtipharm.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 2 Gill Street
  • Woburn, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 2 Gill Street
  • Woburn, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mercury Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2026 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Mercury Therapeutics’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

Mercury Therapeutics FAQs

  • When was Mercury Therapeutics founded?

    Mercury Therapeutics was founded in 1996.

  • Where is Mercury Therapeutics headquartered?

    Mercury Therapeutics is headquartered in Woburn, MA.

  • What industry is Mercury Therapeutics in?

    Mercury Therapeutics’s primary industry is Drug Discovery.

  • Is Mercury Therapeutics a private or public company?

    Mercury Therapeutics is a Private company.

  • What is Mercury Therapeutics’s current revenue?

    The current revenue for Mercury Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process